GeneDx Holdings Corp’s filing revealed that its CHIEF FINANCIAL OFFICER Feeley Kevin unloaded Company’s shares for reported $21582.0 on Jan 29 ’25. In the deal valued at $78.48 per share,275 shares were sold. As a result of this transaction, Feeley Kevin now holds 2,950 shares worth roughly $0.21 million.
Then, Stueland Katherine sold 1,657 shares, generating $130,046 in total proceeds. Upon selling the shares at $78.48, the Chief Executive Officer now owns 3,937 shares.
Before that, ICAHN SCHOOL OF MEDICINE AT MO bought 1,346,123 shares. GeneDx Holdings Corp shares valued at $104,809,137 were divested by the Stockholder at a price of $77.86 per share.
Wells Fargo initiated its GeneDx Holdings Corp [WGS] rating to an Equal weight in a research note published on August 28, 2024; the price target was $34. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who began to cover the stock in early July with a ‘”a Buy”‘ rating.
Price Performance Review of WGS
On Monday, GeneDx Holdings Corp [NASDAQ:WGS] saw its stock fall -6.51% to $69.98. Over the last five days, the stock has lost -6.52%. GeneDx Holdings Corp shares have fallen nearly -8.95% since the year began. Nevertheless, the stocks have risen 1717.66% over the past one year. While a 52-week high of $98.87 was reached on 01/07/25, a 52-week low of $3.62 was recorded on 01/16/25. SMA at 50 days reached $77.52, while 200 days put it at $46.82.
Levels Of Support And Resistance For WGS Stock
The 24-hour chart illustrates a support level at 67.81, which if violated will result in even more drops to 65.63. On the upside, there is a resistance level at 72.68. A further resistance level may holdings at 75.37. The Relative Strength Index (RSI) on the 14-day chart is 42.09, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.18, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 83.91%. Stochastics %K at 28.37% indicates the stock is a holding.
How much short interest is there in GeneDx Holdings Corp?
A steep rise in short interest was recorded in GeneDx Holdings Corp stocks on 2025-01-15, dropping by 10029.0 shares to a total of 2.14 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 2.15 million shares. There was a decline of -0.47%, which implies that there is a negative sentiment for the stock.
